Q: I am down about 20% due to a failed drug test. I understand more drugs coming. Due I hold or sell and move on to NVDA or CGNX.
Great new site and thanks for all your guidance.
Dave.
Great new site and thanks for all your guidance.
Dave.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I have small position in CELG (about 2%). With the recent weakness in the last week, would you suggest holding onto it, or even buying more? If I were to sell is there another healthcare stock you would suggest?
Q: If I may follow up to today's question about celgene; how does the lack of a dividend paid by celgene bring you to recommend against moving towards a 5% position?
Can you please explain your rationale?
Most growth stock do not pay dividends, yet you have in the passed given the 'ok' for full position ( goog, fb)
Thank you
Karim
Can you please explain your rationale?
Most growth stock do not pay dividends, yet you have in the passed given the 'ok' for full position ( goog, fb)
Thank you
Karim
Q: I currently own a 3.5 % position in celgene. Yesterday's accouncement of a failure to proceed to a phase 3 drug trial has led to two analyst downgrades. The stock is down 6 percent pre market. Would you be comfortable, at this moment, to top up to 5%? Or do you see more downside for the company, and would prefer to let things settle.
Thank you
Karim
Thank you
Karim
Q: are you aware of any news that would result in a $7 drop (over 5%) in price?
ed in montreal
ed in montreal
Q: My biotech holdings include Celegene at 3% and alexion at 1.5%. I am looking to obtain a basket of these stocks, the best in your opinion, as opposed to getting the sector etf.
My question are as follows:
1. Do you feel now is an opportune time to be adding to biotech, or has the sector run up too far?
2. If the time is right, what would be your top complementary picks to my current positions ( mid cap to large cap) and how many should I hold? Please advise what an adequate overall portfolio position would be for the sector, for an investor with a palate for moderate risk and a long way term view.
Thank you for your counsel,
Karim .
My question are as follows:
1. Do you feel now is an opportune time to be adding to biotech, or has the sector run up too far?
2. If the time is right, what would be your top complementary picks to my current positions ( mid cap to large cap) and how many should I hold? Please advise what an adequate overall portfolio position would be for the sector, for an investor with a palate for moderate risk and a long way term view.
Thank you for your counsel,
Karim .
Q: good day to you all
would appreciate your updated opinion on Celg
thanks in advance
would appreciate your updated opinion on Celg
thanks in advance
Q: Dear Team,
It appears that biotech companies receive increasingly more attention again. How would you rate above companies and their growth potential over the next two years.
Thank you, as always!
It appears that biotech companies receive increasingly more attention again. How would you rate above companies and their growth potential over the next two years.
Thank you, as always!
-
Biogen Inc. (BIIB)
-
Celgene Corporation (CELG)
-
Gilead Sciences Inc. (GILD)
-
iShares Biotechnology ETF (IBB)
-
bluebird bio Inc. (BLUE)
Q: Would you put money into biotech seasonally ? In the past I have done well on Celgene ... However , I have taken quite a hit on Gillead, so I am cautious.
Or should I look at the ETFs for a broader/safer play ?
Or should I look at the ETFs for a broader/safer play ?
Q: Hi Peter
I am looking to switch my Giliad for JNJ or Celgene in a retirement portfolio. Please advise THank you
Hamish
I am looking to switch my Giliad for JNJ or Celgene in a retirement portfolio. Please advise THank you
Hamish
Q: Could I have your view on there 3rd quarter report. Would you say this stock is a strong buy?
Q: Peter, while the US biotech sector has continued to correct, CELG seems to have stabilised and some analysts are a fan. I am thinking of adding it to my $US account with a 2 year time frame. I do not currently hold any other biotech stocks. Any thoughts? Any alternative stocks I should consider?
Q: Hi, I'm looking to consolidate some US holdings. In my RRSP I'm considering selling either Electronics For Imaging (EFII) or Qualcomm (QCOM) and buy more Celgene (CELG). In my LIRA I'm considering taking my losses on Mosaic (MOS) and buy more of either Apple (AAPL) or Cooper (COO). What do you think of these trades? Thanks again!